Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ayman Samkari

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Pediatric Neurosurgery|August 16, 2018
Synchronous Primary Central Nervous System and Pulmonary Lymphoma in a 7-Year-Old Female with Unspecified T-Cell ImmunodeficiencyMichael G Z Ghali, Ayman Samkari, J Steve Hou, et al.
Future Oncology (London, England)|May 23, 2023
Clinical and economic impact of recurrence in early-stage non-small-cell lung cancer following complete resectionHoward West, Xiaohan Hu, Diana Chirovsky, et al.
Pharmacoeconomics|December 6, 2018
Q-TWiST Analysis to Assess Benefit-Risk of Pembrolizumab in Patients with PD-L1-Positive Advanced or Metastatic Non-small Cell Lung CancerMin Huang, M Catherine Pietanza, Ayman Samkari, et al.
Human Pathology|November 8, 2011
Total Survivin and acetylated Survivin correlate with distinct molecular subtypes of breast cancerEvgeny Yakirevich, Ayman Samkari, Michael P Holloway, et al.
JTO Clinical and Research Reports|April 11, 2022
Non-Small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ): Measurement Properties and Estimated Clinically Meaningful Thresholds From a Phase 3 StudyPaul Williams, Thomas Burke, Josephine M Norquist, et al.
Journal of Managed Care & Specialty Pharmacy|July 5, 2023
Evaluation of disease-free survival as a predictor of overall survival and assessment of real-world burden of disease recurrence in resected early-stage non-small cell lung cancerHoward West, Xiaohan Hu, Su Zhang, et al.
Clinical Lung Cancer|January 14, 2023
Treatment Patterns and Outcomes in Resected Early-stage Non-small Cell Lung Cancer: An Analysis of the SEER-Medicare DataHoward West, Xiaohan Hu, Su Zhang, et al.
Lung Cancer (Amsterdam, Netherlands)|June 18, 2022
Chemoradiation-induced pneumonitis in patients with unresectable stage III non-small cell lung cancer: A systematic literature review and meta-analysisYuting Kuang, Christine M Pierce, Hsiu-Ching Chang, et al.
Clinical Lung Cancer|April 16, 2024
Real-World Neoadjuvant Treatment Patterns and Outcomes in Resected Non-Small-Cell Lung CancerJessica Donington, Xiaohan Hu, Su Zhang, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 13, 2023
Event-free survival as a predictor of overall survival and recurrence burden of patients with non-small cell lung cancer receiving neoadjuvant therapyJessica Donington, Xiaohan Hu, Su Zhang, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Pediatric Neurosurgery|August 16, 2018
Synchronous Primary Central Nervous System and Pulmonary Lymphoma in a 7-Year-Old Female with Unspecified T-Cell ImmunodeficiencyMichael G Z Ghali, Ayman Samkari, J Steve Hou, et al.
Future Oncology (London, England)|May 23, 2023
Clinical and economic impact of recurrence in early-stage non-small-cell lung cancer following complete resectionHoward West, Xiaohan Hu, Diana Chirovsky, et al.
Pharmacoeconomics|December 6, 2018
Q-TWiST Analysis to Assess Benefit-Risk of Pembrolizumab in Patients with PD-L1-Positive Advanced or Metastatic Non-small Cell Lung CancerMin Huang, M Catherine Pietanza, Ayman Samkari, et al.
Human Pathology|November 8, 2011
Total Survivin and acetylated Survivin correlate with distinct molecular subtypes of breast cancerEvgeny Yakirevich, Ayman Samkari, Michael P Holloway, et al.
JTO Clinical and Research Reports|April 11, 2022
Non-Small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ): Measurement Properties and Estimated Clinically Meaningful Thresholds From a Phase 3 StudyPaul Williams, Thomas Burke, Josephine M Norquist, et al.
Journal of Managed Care & Specialty Pharmacy|July 5, 2023
Evaluation of disease-free survival as a predictor of overall survival and assessment of real-world burden of disease recurrence in resected early-stage non-small cell lung cancerHoward West, Xiaohan Hu, Su Zhang, et al.
Clinical Lung Cancer|January 14, 2023
Treatment Patterns and Outcomes in Resected Early-stage Non-small Cell Lung Cancer: An Analysis of the SEER-Medicare DataHoward West, Xiaohan Hu, Su Zhang, et al.
Lung Cancer (Amsterdam, Netherlands)|June 18, 2022
Chemoradiation-induced pneumonitis in patients with unresectable stage III non-small cell lung cancer: A systematic literature review and meta-analysisYuting Kuang, Christine M Pierce, Hsiu-Ching Chang, et al.
Clinical Lung Cancer|April 16, 2024
Real-World Neoadjuvant Treatment Patterns and Outcomes in Resected Non-Small-Cell Lung CancerJessica Donington, Xiaohan Hu, Su Zhang, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 13, 2023
Event-free survival as a predictor of overall survival and recurrence burden of patients with non-small cell lung cancer receiving neoadjuvant therapyJessica Donington, Xiaohan Hu, Su Zhang, et al.
Pageof 4